1. Home
  2. COLL vs MOMO Comparison

COLL vs MOMO Comparison

Compare COLL & MOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • MOMO
  • Stock Information
  • Founded
  • COLL 2002
  • MOMO 2011
  • Country
  • COLL United States
  • MOMO China
  • Employees
  • COLL N/A
  • MOMO N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • MOMO Computer Software: Prepackaged Software
  • Sector
  • COLL Health Care
  • MOMO Technology
  • Exchange
  • COLL Nasdaq
  • MOMO Nasdaq
  • Market Cap
  • COLL 958.8M
  • MOMO 909.4M
  • IPO Year
  • COLL 2015
  • MOMO 2014
  • Fundamental
  • Price
  • COLL $30.35
  • MOMO $8.37
  • Analyst Decision
  • COLL Strong Buy
  • MOMO Buy
  • Analyst Count
  • COLL 4
  • MOMO 2
  • Target Price
  • COLL $43.75
  • MOMO $10.00
  • AVG Volume (30 Days)
  • COLL 289.9K
  • MOMO 1.9M
  • Earning Date
  • COLL 08-07-2025
  • MOMO 09-02-2025
  • Dividend Yield
  • COLL N/A
  • MOMO 3.54%
  • EPS Growth
  • COLL N/A
  • MOMO N/A
  • EPS
  • COLL 1.25
  • MOMO 1.06
  • Revenue
  • COLL $664,283,000.00
  • MOMO $1,450,201,337.00
  • Revenue This Year
  • COLL $20.04
  • MOMO $0.97
  • Revenue Next Year
  • COLL $3.98
  • MOMO $4.25
  • P/E Ratio
  • COLL $24.19
  • MOMO $7.99
  • Revenue Growth
  • COLL 17.17
  • MOMO N/A
  • 52 Week Low
  • COLL $23.23
  • MOMO $5.12
  • 52 Week High
  • COLL $42.29
  • MOMO $8.83
  • Technical
  • Relative Strength Index (RSI)
  • COLL 54.25
  • MOMO 66.26
  • Support Level
  • COLL $29.28
  • MOMO $8.24
  • Resistance Level
  • COLL $30.83
  • MOMO $8.83
  • Average True Range (ATR)
  • COLL 0.75
  • MOMO 0.25
  • MACD
  • COLL -0.00
  • MOMO -0.07
  • Stochastic Oscillator
  • COLL 51.63
  • MOMO 46.62

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About MOMO Hello Group Inc.

Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.

Share on Social Networks: